title: [Can the second-generation tyrosine kinase inhibitors be as first-line treatment strategy in newly diagnosed chronic phase chronic myeloid leukemia patients?].
authors.affiliation: Department of Hematology, Union Hospital,Tongji Medical College, Huazhong University of Scinence and Technology, Wuhan 430022, China.
authors.forename: Ping
authors.initials: P
authors.lastname: Zou
mesh_terms: D006801:Humans; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive; D015466:Leukemia, Myeloid, Chronic-Phase / Q000188:drug therapy*; D011505:Protein-Tyrosine Kinases / Q000037:antagonists & inhibitors*
chemical_list: D011505:Protein-Tyrosine Kinases